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Abstract: Cues from the material to which a cell is adher-
ent (e.g., adhesion ligand presentation, substrate elastic
modulus) clearly influence the phenotype of differentiated
cells. However, it is currently unclear if stem cells respond
similarly to these cues. This study examined how the over-
all density and nanoscale organization of a model cell ad-
hesion ligand (arginine-glycine-aspartic acid [RGD] con-
taining peptide) presented from hydrogels of varying stiff-
ness regulated the proliferation of a clonally derived stem
cell line (D1 cells) and preosteoblasts (MC3T3-E1). While
the growth rate of MC3T3-E1 preosteoblasts was respon-
sive to nanoscale RGD ligand organization and substrate
stiffness, the D1 stem cells were less sensitive to these cues
in their uncommitted state. However, once the D1 cells
were differentiated towards the osteoblast lineage, they
became more responsive to these signals. These results
demonstrate that the cell response to material cues is de-
pendent on the stage of cell commitment or differentiation,
and these findings will likely impact the design of bioma-
terials for tissue regeneration.  2007 Wiley Periodicals,
Inc. J Biomed Mater Res 85A: 145–156, 2008
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INTRODUCTION
The remarkable capability of stem cells to differen-
tiate and express markers typical of a variety of cell
types has led to the hope that they will one day be
utilized to repair or regenerate tissues.1–4 Adult
tissue-derived stem cell populations are particularly
appealing for near-term applications due to their
ready availability, and straightforward applicability
to autologous cell transplantation therapies. How-
ever, to harness the potential of stems cells for cell-
based therapies, their proliferation and differentia-
tion must be tightly regulated. Microenvironmental
cues, including soluble factors, cell–cell interactions,
and extracellular matrix (ECM) signals, are clearly
critical to this regulation. Most research to date has
focused on the use of soluble signals to direct stem
cell fate, as both multipotent embryonic stem cells
and less plastic cell populations derived from adult
tissues are regulated by a variety of morphogens
and growth factors.2,5
ECM cues, including the types and organization of
adhesion ligands, and the physical properties (e.g.
stiffness) of the substrate presenting these cues play
important roles in defining the phenotype of differ-
entiated cell populations,6–10 but it is currently
unclear if stem cells similarly respond to these cues.
ECM control over differentiated cell phenotype has
provided a basis for the design of materials that can
be used to manipulate these cells in vitro and
in vivo,11–13 and these synthetic matrices are fre-
quently a prominent component of cell-based thera-
pies (e.g., engineered skin tissue).14–18 While it is
anticipated that this approach will be similarly use-
ful in stem cell therapies, the current lack of infor-
mation regarding the ECM cue–stem cell fate rela-
tion hampers progress in the design of synthetic
ECM analogs for these applications.
This study investigated how specific ECM cues
(adhesion ligand density, spacing, and matrix stiff-
ness) regulate the proliferation of a stem cell line,
and compared this relation to that obtained with
cells committed to a specific fate (preosteoblasts). A
model ECM was used in this study, which consisted
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Ricerca; contract grant number: PNR 2001-2003 (FIRB art. 8)
' 2007 Wiley Periodicals, Inc.
of an otherwise nonadhesive polysaccharide (algi-
nate), in the physical form of a hydrogel, which
presents covalently coupled cell adhesive ligands.
Synthetic peptides containing the well-characterized
arginine-glycine-aspartic acid (RGD) binding
sequence for integrin receptors19 were used as the
model adhesion ligand, and the density and organi-
zation of these peptides presented from the gels was
varied. To vary the substrate elastic modulus, the
extent of gel crosslinking was controlled.20
Two cell lines, a clonally derived stem cell line
(D1)21 derived from murine bone marrow, and a clo-
nally derived murine preosteoblast line (MC3T3-E1),
were selected and used to compare the dependence
of stem cell versus differentiated cell proliferation on
matrix cues. The use of clonally derived cell lines is
critically important in these types of studies, as it
allows one to directly determine if one is changing
the fate of a cell type, versus the confounding issue
of selecting for a subpopulation of cells in a hetero-
geneous population.22 The ability of D1 cells to
differentiate down an osteoblast, chondrocyte, and
adipocyte lineage has been described23–25 and their
osteogenic differentiation in response to ascorbic
acid and b-glycerophosphate has been well charac-
terized. D1 cells express osteocalcin and type I colla-
gen (a1)2a2 mRNA as well as high levels of alkaline
phosphatase and matrix mineralization in vitro.21 In
addition, D1 cells loaded in diffusion chambers and
implanted intraperitoneally in MF1 nu/nu athymic
mice stained positively for alkaline phosphatase ac-
tivity and matrix mineralization.21 The more commit-
ted MC3T3-E1 preosteoblasts are a commonly used
model to study osteoblast differentiation.26–30 The
preosteoblast cell response to matrix RGD ligand
presentation and elastic modulus was first character-
ized in these studies and used to establish the com-
mitted cell response to matrix cues. The role of the
stage of cell differentiation on the cell response to
ECM cues was then studied with the D1 cells by
comparing their response in the undifferentiated
state to that in which the cells were induced toward
the osteoblast lineage prior to studies on the role of
ECM cues on their proliferation. Proliferation was
utilized as an endpoint in these studies as it has pre-
viously been demonstrated that matrix properties
such as RGD ligand presentation and degradation
that control cell proliferation in vitro do result in pro-
found functional differences in cell fate and tissue
formation.13,31–33 For example, RGD ligand presenta-
tion from an alginate hydrogel not only enhanced
MC3T3-E1 preosteoblast proliferation in vitro but
also enhanced the extent of bone formed in a mouse
subcutaneous model.13 Furthermore, properties such
as scaffold degradation rate also regulate the amount
of bone formed from human mesenchymal stem
cells.33 Although the studies in this paper focused
on the effects of adhesion ligand presentation on cell
growth rate, these results likely have implications




Murine preosteoblast MC3T3-E1-E1 cells, a generous gift
from Dr. M. Kumegawa (Josai Dental University, Sakado,
Japan), were cultured in a-MEM media (without ascorbic
acid; Invitrogen, Carlsbad, CA) supplemented with 10% fe-
tal bovine serum (FBS; Invitrogen) and 100 U/mL penicil-
lin–streptomycin (PS; Invitrogen). A mouse clonally
derived bone marrow stromal cell line (D1 cells21; ATCC,
Manassus, VA) was cultured in DMEM media (Invitrogen)
supplemented with 10% FBS (Invitrogen) and 100 U/mL
PS. Human bone marrow stromal cells (hBMSCs) were iso-
lated from bone marrow aspirate (National Disease
Research Interchange, Philadelphia, PA) using Ficoll-Paque
(GE Healthcare, Piscataway, NJ) and cultured in a-MEM
media (Invitrogen), 10% FBS and 100 U/mL PS. For analy-
sis of cell morphology, cells were labeled with octadecyl
rhodamine B chloride R18 (Invitrogen) for 24 h prior to
seeding, and photomicrographs were obtained 5 h post-
seeding using an Olympus IX81 (Melville, NY) inverted
microscope and IP Lab software (Scanalytics, Rockville,
MD). All three cell types were seeded onto alginate sub-
strates (no RGD, RGE and RGD [various spacings]) in
serum-containing media.
Preparation of adhesion substrates
Peptide-modified alginate was prepared using standard
carbodiimide chemistry as described previously34 from
Ultrapure MVG (Pronova, Oslo, Norway) alginate and
either linear Gly4-Arg-Gly-Asp-Ser-Pro (G4RGDSP) or cyclic
Gly4-Cys-Arg-Gly-Asp-Ser-Pro-Cys (G4CRGDSPC) peptides
for murine cell lines and human primary cells, respectively
(Commonwealth Biotechnologies, Richmond, VA). In lieu
of employing RGD-modified alginates with the extremely
high DS required for hBMSC proliferation studies, we
used cyclic RGD peptides which enhance cell adhesion
and proliferation over linear RGD peptides.35 Alginates
were reconstituted in a-MEM media containing 1% PS to
make a 2% hydrogel solution. All chemicals were obtained
from Sigma-Aldrich (St. Louis, MO) unless otherwise
noted. Alginate hydrogels were ionically crosslinked using
calcium sulfate slurry in a 25:1 molar ratio before casting
between glass plates. Disks (10 mm diameter, 1 mm thick)
were made using an arch punch (McMaster-Carr, Atlanta,
GA), and maintained in a-MEM media with 1% PS over-
night until cell seeding.
To vary the elastic moduli, hydrogels were prepared by
varying the amount of crosslinking as previously
described.36 Alginate hydrogels were prepared by mixing
1 part of 210 mg/mL CaSO4 (Sigma) in water with 100, 25,
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12.5 parts of 2% (w/w) alginate solution in a-MEM to
modulate the mechanical stiffness of the gels. The stiffness
of the gels was evaluated by measuring the compressive
elastic moduli (E) with a mechanical tester (MTS Bionix
100; MTS systems, Eden Prairie, MN).
Osteogenic predifferentiation
In certain studies, D1 cells were predifferentiated for 14
days in DMEM media (Invitrogen) with 10% FBS (Invi-
trogen) and 100 U/mL PS, supplemented with 10 ng/mL
BMP-2 (Cell Sciences, Canton, MA), 50 lg/mL ascorbic
acid, and 10 mM b-glycerophosphate (Sigma). For differen-
tiation studies, D1 cells were expanded in DMEM media
with 10% FBS (Invitrogen), 50 lg/mL ascorbic acid, and
100 U/mL PS, as described by Diduch et al. The state of
differentiation was analyzed by quantifying calcium depo-
sition and osteocalcin secretion, and staining for mineral
deposition (von Kossa). The calcium content of cell lysates
prepared by dissolving cultures with 1M HCl was assayed
using a calcium kit (Wako Pure Chemical, Japan) accord-
ing to manufacturer’s instructions. Osteocalcin levels in
cell lysates prepared by incubating cells in passive lysis
buffer (Promega, Madison, WI) were assayed using a
mouse osteocalcin ELISA kit (Biomedical Technologies,
Stoughton, MA) according to manufacturer’s instructions.
For staining, cell layers were fixed in 70% ethanol and a
5% silver nitrate solution was applied to the cell layer and
exposed to light for 15 min. Unreacted silver nitrate was
removed by addition of 5% sodium thiosulfate. Cell layers
were rinsed several times in PBS prior to obtaining von
Kossa staining images with an Olympus IX81 (Melville,
NY) inverted microscope.
Cell proliferation
Cells were seeded onto alginate disks at a seeding den-
sity of 10,000 cells/cm2 and allowed to adhere for 5 h.
Disks were then transferred to new plates and fresh media
was added. At 5 h and days 1, 2, and 4, disks were trans-
ferred to 15-mL tubes containing 1 mL of trypsin (Invi-
trogen), incubated for 5 min (378C), and 50 mM EDTA/
PBS (pH 7.4) was added to each tube to dissolve the disks.
Cell counts from the solution were obtained using a Z2
Coulter Counter (Beckman Coulter, Fullerton, CA). Quad-
ruplicate samples were assayed for each condition. Growth
rates were calculated from cell counts comparing cell num-
bers at day 4 to cell numbers 5 h post-seeding. For 3H thy-
midine incorporation, cells were incubated at each time
point with 2 lCi 3H thymidine (Perkin Elmer, Wellesley,
MA) for 24 h. Media was removed and each disk was
rinsed twice with cold PBS to remove unincorporated 3H
thymidine. Disks were dissolved in 2 mL of 50 mM
EDTA/PBS (pH 7.4) at 378C, and then centrifuged at
14,400 rpm at 48C for 5 min. Upon removal of the superna-
tant, the cell pellet was rinsed in 5% cold TCA in PBS and
centrifuged again at 14,400 rpm. The cell pellet was solubi-
lized in 0.5 mL of 10.25N NaOH. Ultima Gold XR was
added to each sample prior analysis using a TriCarb
2800TR liquid scintillation counter (Perkin Elmer).
Reverse transcription-PCR
D1 cells were seeded at 5000 cells/cm2 in 12-well tissue
culture plates and cultured for 14 days in DMEMmedia only
or with osteogenic supplements (as described earlier). At
days 3 and 14, RNA was isolated from samples using a
RNeasy mini kit (Qiagen). RNA was quantified using the
Nanodrop (Nanodrop Technologies) and analyzed using the
Bioanalyzer RNA Nano kit (Agilent Technologies). One
microgram of each RNA sample was reverse transcribed to
cDNA in a 50 lL reaction using the high capacity cDNA
archive kit (Applied Biosystems). The PCR reaction was per-
formed using the primers for osteocalcin and GAPDH (Invi-
trogen) and the HotStarTaq Plus PCR kit (Qiagen) using a MJ
Tetrad Thermal Cycler (Bio-Rad). Cycling conditions were:
5 min activation at 958C, 1 min denaturation at 948C, 1 min
annealing at 608C, 1 min extension at 728C for 35 cycles, and
a final extension for 10 min at 728C. Primer sequences








Values represent mean (n ¼ 3 or 4) and standard devia-
tion. Statistical significance of data was assessed using one
way ANOVA with respect to substrate conditions for the
respective experiment (either varying RGD island spacing,
bulk density, or elastic modulus), followed by a post-hoc
comparison using the Tukey test. * represents p < 0.05
between noted conditions.
RESULTS AND DISCUSSION
To regulate adhesion ligand presentation to the
cells in this study, the number of peptides per algi-
nate chain (degree of substitution [DS]) was altered
to control the total density of adhesion peptides pre-
sented from the material [Fig. 1(A)]. RGD-modified
polymer chains were also combined with unmodi-
fied polymer chains (DS ¼ 0) at various ratios to cre-
ate adhesive islands in the gels [Fig. 1(B)], and alter
the nanoscale ligand spacing.38–40 The DS of the
modified polymer chains can be altered in parallel
with the island spacing to maintain an overall con-
stant RGD total density in each series of gels, and
the extent of ionic crosslinking was also manipulated
to control the stiffness of the gel substrate from
which the ligands were presented to cells (Table I).
The effect of adhesion peptide presentation (total
density and nanoscale organization) on the adhesion
of preosteoblasts and stem cells was first investigated.
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Alginate substrates which did not present RGD
ligands did not promote proliferation of MC3T3
preosteoblasts and D1 stem cells (data not shown).
However, both cell types readily adhered and
spread on RGD-modified surfaces [Fig. 2(A,B)]. The
number of cells adhered onto the RGD-modified
alginates 5 h post-seeding were comparable across
RGD island spacings examined in this study, pre-
sumably due to the presentation of the same overall
RGD total density (although presented in different
patterns) in this system. The MC3T3-E1 preosteo-
blasts were more elongated and spindle-shaped than
the D1 stem cells; the projected area on the surface
was greater for MC3T3 cells [Fig. 2(C)]. Overall cell
spreading was decreased in cells seeded onto RGD-
presenting substrates of increased RGD island spac-
ings (data not shown). As a control, MC3T3 and D1
cells were cultured on surfaces presenting RGE pep-
tides, a nonsense peptide sequence, to confirm that
cell adhesion and proliferation in our experiments
were RGD mediated. Although the cell numbers
increased threefold 48 h post-seeding on the RGD-
modified surfaces, the RGE-modified surfaces did
not promote the growth of D1 cells [Fig. 2(D)] nor
MC3T3 cells (data not shown).
The growth rate of the two cell types was then
examined to determine the cell responsiveness to the
density and nanoscale presentation of adhesion
ligands. In these experiments, the DS (2–40) as well
as the spacing between RGD islands (36–121 nm)
was varied while maintaining a constant RGD total
density (1.25, 6.25, or 12.5 mg RGD/g alginate)
across a series of island spacings. The growth rates
of both stem cells and preosteoblasts generally
increased as the total RGD density increased,
although the sensitivity of the D1 cells to the total
RGD density was slightly decreased, when com-
pared with the MC3T3-E1 cells. The proliferation of
both cell types was also dependent on the RGD
island spacing at each constant RGD total density
[Fig. 3(A,B)]. 3H thymidine incorporation assays
were used to analyze whether observed increases in
cell numbers were due to an upregulation in DNA
synthesis specifically, and this analysis corroborated
the direct cell counts. DNA synthesis increased with
the total RGD density and decreased as the RGD
island spacing was increased from 36 to 121 nm
[Fig. 3(C,D)]. These results are generally consistent
with past studies demonstrating rat embryonic fibro-
blasts spreading and cell numbers increased as RGD
ligand distances were decreased from 110 to 58
nm,41 and the importance of nanoscale RGD cluster-
ing and spacing on cell adhesion and motility.42 No
significant cell apoptosis, assessed by annexin stain-
ing, was observed in these experiments (data not
shown), indicating that the differences in cell num-
bers were directly related to changes in proliferation.
To directly compare the dependency of preosteo-
blasts and stem cells on RGD presentation, cell
growth rates on RGD-modified hydrogels were nor-
malized, and D1 progenitor cell proliferation was
clearly less responsive to RGD island spacing than
MC3T3-E1 proliferation [Fig. 3(E)]. Normalization is
with respect to the cell’s growth rate at an RGD
island spacing of 121 nm (overall RGD density of
12.5 mg/g alginate) for both cell types. The normal-
ization trends observed for this ligand density also
extends to a ligand density of 6.25 mg/g alginate,
although the effect is less pronounced (data not
shown). The trends observed were consistent within
the range of ligand densities investigated.
The response of the committed cells to adhesion
ligand presentation is typically dependent on the
mechanical properties of the substrate presenting the
peptides,8,40 and the elastic modulus (E) of the adhe-
sion substrate in these studies was varied to deter-
mine its effect on the growth rates of both cell types.
Increasing the elastic modulus of the substrate
enhanced MC3T3-E1 preosteoblast proliferation
Figure 1. Experimental system. A: Polymer chains were
either modified with coupled RGD peptides (DS 4 is
shown; top) or left with no coupled RGD peptides
(unmodified alginate, DS 0; bottom). B: The spacing
between polymer chains containing RGD ligands (island
spacing) was controlled by mixing RGD-modified alginate
of various DS with unmodified alginate in various ratios.
The overall RGD density (total density) was kept constant
by altering DS in parallel with changes in island spacing.
[Color figure can be viewed in the online issue, which is
available at www.interscience.wiley.com.]
TABLE I








0.2 1.25 85 60
0.2 1.25 121 60
1 6.25 36 60
1 6.25 85 60
1 6.25 121 60
2 12.5 36 20, 60, 110
2 12.5 85 60
2 12.5 121 60
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[Fig. 4(A)], as anticipated from past studies.36 How-
ever, the proliferation of D1 stems cells was not de-
pendent on the substrate elastic modulus [Fig. 4(B)].
Comparison of normalized MC3T3-E1 and D1 cell
growth rates clearly demonstrate the difference in
their dependency on substrate stiffness [Fig. 4(C)].
Altogether, these observations indicate that these
stem cells were less responsive to matrix cues such
as adhesion ligand presentation and substrate me-
chanical properties than the more committed cell
line.
To confirm that the stage of differentiation con-
trols cell proliferation dependence on matrix cues,
the D1 cells were precultured in media with osteo-
genic supplements (50 lg/mL ascorbic acid and
10 mM b-glycerophosphate21) to drive them down an
Figure 2. Cell adhesion and proliferation on RGD-modified alginate hydrogels. Fluorescent images of MC3T3 cells (A)
and D1 cells (B) 5 h post-seeding onto RGD-modified hydrogels (3200). C: The cell aspect ratio, defined as the ratio
between long axis and short axis of cells, and projected areas of the two cell types on the substrate (RGD total density
12.5 mg RGD/g alginate) in (A, B) as determined by image analysis of at least four disks per condition. D: The fraction of
initial cells adhered on RGE- and RGD-modified substrates (total density 12.5 mg RGE or RGD per g alginate). Values rep-
resent mean and standard deviation. * represents p < 0.05 between the two cell types in (C) and RGE- and RGD-modified
substrates (D).
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Figure 3. Growth rates and DNA synthesis of MC3T3 and D1 cells as RGD presentation is varied. MC3T3 (A, C) and D1 cells
(B, D) were cultured on gels that presented varying total densities of RGD ligands, and varying spacings between RGD
islands. The growth rates of MC3T3 (A) and D1 cells (B), calculated from changes in cell number over time, were greater as
the total RGD density was increased, but the growth rates decreased as the RGD island spacing increased at a constant RGD
total density. Analysis of DNA synthesis in MC3T3 (C) and D1 cells (D) confirmed that cell proliferation was enhanced at
lower RGD island spacings (overall RGD total density maintained at 12.5 mg/g alginate). E: Comparison of normalized
growth rates of MC3T3 (circles) and D1 (squares) cells revealed that D1 cells were less sensitive to RGD island spacing than
MC3T3 cells. Growth rates were normalized to that obtained with each cell type at the greatest island spacing (at a single
ligand density of 12.5 mg/g alginate). The normalization trends observed for this ligand density also extends to ligand density
of 6.25 mg/g alginate, although the effect is less pronounced. Values on all graphs represent mean and standard deviation
(n ¼ 4). * represents p < 0.05 between noted conditions in (A–E). [RGD] is RGD total density in mg/g alginate.
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osteogenic pathway before matrix studies were per-
formed. The D1 cells cultured in this media mineral-
ized over time [Fig. 5(B)], whereas D1 cells cultured
in media without osteogenic supplements [Fig. 5(A)]
did not mineralize, as demonstrated by von Kossa
staining. Lysates of D1 cells cultured with and with-
out osteogenic supplements were also quantitatively
assayed for calcium deposition [indicative of miner-
alization; Fig. 5(C)] and osteocalcin [Fig. 5(D)], a late
stage bone specific marker. To confirm previously
published data, osteocalcin mRNA levels were also
assessed; osteocalcin mRNA was observed in D1
cells cultured in the presence of osteogenic supple-
ments [Fig. 5(E)]. These assays confirmed that the
D1 cells differentiated toward an osteoblast pheno-
type when cultured in media with the osteogenic
supplements (these cells will be referred to as pre-
differentiated D1 cells). It was also observed that
addition of recombinant human bone morphoge-
netic protein 2 (BMP-2) with ascorbic acid and b-
glycerophosphate enhanced the differentiation and
mineralization of the D1 cells (data not shown).
Predifferentiated D1 cells were subsequently cul-
tured on substrates with varying RGD presentation
and elastic moduli, and their proliferation quantified.
Strikingly, increasing the RGD density enhanced the
growth rate of these predifferentiated D1 cells [Fig.
6(A)], and these predifferentiated D1 cells showed a
similar response to adhesion ligand density as the
MC3T3-E1 cells. The predifferentiated D1 cell growth
rates were also quite sensitive to RGD island spac-
ings [Fig. 6(B)]. Indeed, comparison of normalized
proliferation rates of these cells to the MC3T3-E1
and undifferentiated D1 cells indicated that predif-
ferentiation made the D1 cells as responsive to RGD
presentation as the MC3T3-E1 cells, and more re-
sponsive than the undifferentiated D1 cells [Fig.
6(C)]. The growth rates of predifferentiated D1 cells
were also enhanced as the substrate elastic modulus
was increased, in a similar manner as observed for
the MC3T3-E1 preosteoblasts [Fig. 6(D)].
In all of these experiments, well-characterized, clo-
nally derived cell lines were used to investigate ECM
cues on cell growth. These experiments were next
extended by performing similar experiments with the
primary hBMSCs widely used in tissue regeneration
and engineering studies as these cells have recently
been demonstrated to respond to geometric and me-
chanical cues from the adhesion substrate.22,43,44 We
investigated the growth rate response of the hetero-
geneous hBMSC population to RGD ligand presenta-
tion and substrate stiffness and compared how the
cell response differed from that of a clonally derived
cell population. HBMSC growth was strongly influ-
enced by total RGD density and island spacing [Fig.
7(A,B)]. This dependence was similar in magnitude
to that of MC3T3-E1 cells, and much greater than that
observed with D1 cells before they were differenti-
ated. Increasing the substrate elastic modulus (at a
constant overall RGD density of 125 mg/g alginate)
also led to greater hBMSC proliferation [Fig. 7(C)],
and their response to this cue was similar to the
MC3T3-E1 response. Again, the magnitude of this
Figure 4. Substrate stiffness control of MC3T3 and D1
cell proliferation. Proliferation of MC3T3 (A) and D1 (B)
cells when cultured on substrates presenting a constant,
high total density of RGD (12.5 mg/g alginate) and island
spacing (36 nm), but elastic modulus of 20 kPa (cross), 60
kPa (open triangle), and 110 kPa (open circles). C: Com-
parison of normalized growth rates, relative to growth rate
on gels with modulus of 20 kPa, for MC3T3 preosteoblasts
(closed squares) and D1 cells (closed circles). Values repre-
sent the mean and standard deviation from three inde-
pendent experiments. Differences between the values on
the two highest modulus substrates and the lowest were
statistically significant in (A), as noted by * (p < 0.05), but
not in (B). Differences between growth rates between the
cell types as the moduli were varied were also statistically
significant in (C), as noted by * (p < 0.05).
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Figure 5. Differentiation of D1 stem cells in osteogenic media. D1 cells cultured in media without (A) and with (B) osteo-
genic supplements (50 lg/mL ascorbic acid and 10 mM b-glycerophosphate) were qualitatively assessed for matrix miner-
alization via von Kossa staining. Addition of osteogenic supplements resulted in positive staining (dark regions) for miner-
alization. To quantify the extent of cell differentiation, the calcium content (C) in the cultures, and osteocalcin secretion
(D) of cells cultured with (triangles) and without (squares) osteogenic supplements were analyzed. E: Osteogenic differen-
tiation was also assessed at the genetic level using reverse-transcriptase PCR. Osteocalcin mRNA was observed in samples
cultured in the presence of osteogenic supplements (lanes 1–3 [day 14], triplicate samples). Message levels for a house-
keeping gene, GAPDH, are also shown for each condition to demonstrate evenness of loading. Values represent mean and
standard deviation (n ¼ 3). * represents p < 0.05 between control and condition in which supplements were added. [Color
figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
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effect was greater than that observed for D1 cells
prior to their differentiation, and similar to that
observed with predifferentiated D1 cells. Interest-
ingly, the response of hBMSCs to RGD ligand presen-
tation is intermediate to that of MC3T3-E1 preosteo-
blasts and undifferentiated D1 cells. This finding
Figure 6. Proliferation of predifferentiated D1 cells and MC3T3 preosteoblasts in response to RGD total density and
island spacing. D1 cells were cultured in DMEM media with osteogenic supplements for 14 days (termed predifferentiated
D1 cells) prior to seeding onto RGD-modified hydrogels. The normalized growth rates of predifferentiated D1 (diamonds)
and MC3T3-E1 cells (circles) were determined as a function of total RGD density (A) and decreasing RGD island spacing
(overall RGD total density maintained at 12.5 mg/g alginate) (B). C: Normalization of growth rates, relative to lowest
value in each condition, revealed that predifferentiated D1 cells (diamonds) responded in a similar manner to the RGD
island spacing as MC3T3 preosteoblasts (circles). D: Similarly, comparison of the normalized growth rates of D1 stem cells
(squares), predifferentiated D1 cells (diamonds), and MC3T3 preosteoblasts (circles) revealed that the predifferentiated D1
cells were much more sensitive to the substrate elastic modulus than the undifferentiated D1 cells (constant RGD total
density of 12 mg/g alginate, and constant island spacing of 36 nm for all cell types). Values represent mean and standard
deviation (n ¼ 4). * represent p < 0.05 between values as RGD total density and spacing increased (A, B), and between un-
differentiated D1 and both the MC3T3 preosteoblasts and predifferentiated D1s in (C) and the different cell types in (D).
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suggests that, functionally, this cell population is ei-
ther at an intermediate stage of differentiation or this
heterogeneous population contains a mixture of more
primitive and lineage-committed cells.
These studies clearly indicate that the stage of dif-
ferentiation regulates the cell responses to matrix
cues. D1 stem cells that were less responsive to
matrix cues in their uncommitted state became more
sensitive to these signals once they were differenti-
ated towards the osteoblast lineage. The mechanism
of this transition is unclear, but may be related to
changes in the types or numbers of integrins (cell
surface receptors which mediate ECM interactions)
expressed in committed versus progenitor cell
Figure 7. Proliferation of hBMSC in response to total RGD density, island spacing, and substrate stiffness. Elastic modu-
lus of all conditions was maintained at 60 kPa for these studies. (A) The hBMSC growth rate increased with RGD density
(linear), and (B) with decreasing RGD island spacing (overall cyclic RGD density of 15.2 mg/g alginate). C: Increases in
the substrate elastic modulus led to significant increases in hBMSC proliferation rates (overall RGD density of 12.5 mg/g
alginate). Values represent mean and standard deviation (n ¼ 4). * represents p < 0.05 between noted conditions.
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populations. It has been reported that stromal pro-
genitors constitutively express the laminin receptor,
a6b1, but lack expression of the collagen/laminin
receptor, a3b1, whereas osteoblast-like cells express
a3b1 but lack expression of a6b1.45 As cells differen-
tiate, expression of specific integrins (e.g. avb3) may
be upregulated while others (e.g. b1 integrins) are
downregulated, as observed with studies using
MC3T3 preosteoblasts.46 Integrin receptors contain-
ing the b1 subunit are likely to be especially impor-
tant in the interaction of osteoblast-like cells with
their ECM45,47 and alter the cell response to RGD-
ligand presentation and substrate stiffness. Alterna-
tively, as progenitor cells differentiate, their produc-
tion of enzymes and machinery to control matrix
formation may be altered and thus may feedback to
modify cell responsiveness to the ECM,48 or the in-
tracellular signal transduction pathways triggered
by matrix cues may be altered.
It is widely known that cells are not only sensitive
to substrate stiffness,49 but the cell response is also
dependent on the cell type.10,50 Hepatocytes require
soft substrates to maintain function and a differenti-
ated phenotype, whereas myocytes appear to require
stiffer substrates for myotube formation. Osteoblasts
are typically in an environment in which they are
surrounded by a relatively rigid matrix of collagen
and mineral with an elastic modulus of *100 kPa.43
It is possible that stem cells committed toward the
osteoblast phenotype will exhibit the osteoblast pref-
erence for a stiffer substrate and thus the prediffer-
entiated D1 stem cells may become more responsive
to substrates with higher elastic modulus in a similar
manner as has been reported for hBMSCs.43 How-
ever, it is difficult to discern whether the effects of
matrix stiffness on hBMSC commitment toward spe-
cific lineages are due to a change in cell fate or a
selection for the presence of progenitors already
committed to various lineages. The use of a clonally
derived stem cell population in these studies allows
us to more rigorously examine how ECM cues influ-
ence a homogeneous stem cell population, and elimi-
nates the potentially confounding effects due to the
presence of other progenitor cell types.
Successful cell-based therapies for tissue regenera-
tion require the rational design of optimally
designed biomaterials. The results of this study sug-
gest that the biomaterial design is not ‘‘one size fits
all’’ and must be tailored to the specific stage of cell
differentiation. In this study, we demonstrate that
the presentation of RGD ligands and substrate stiff-
ness exert different effects on osteoprogenitors,
depending on their stage of differentiation. These
effects are anticipated to be relevant to many other
progenitor and stem cell populations as well. Further
understanding of how progenitor cells and commit-
ted cells respond to substrate cues may allow one to
engineer synthetic microenvironments to direct cell
fate and drive tissue regeneration and/or reverse
disease states.
We thank Wendy A. Comisar for providing the scheme
in Figure 1(A,B).
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